ASTRAZENECA PLC
ASTRAZENECA PLC
Aktie · GB0009895292 · 886455 (XLON)
Übersicht Finanzkennzahlen
106,68 GBP
-98,65 % -7.803,01 GBP
Schlusskurs XLON 06.06.2025: 10.770,00 GBX
London · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 17:35

Aktuelle Kurse von ASTRAZENECA PLC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XETR: XETRA
XETRA
ZEG.DE
EUR
06.06.2025 15:35
127,95 EUR
127,15 EUR
+0,63 %
XLON: London
London
AZN.L
GBX
06.06.2025 15:14
10.770,00 GBX
10.688,00 GBX
+0,77 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 1,11 % -0,82 % -11,62 % -0,54 % -15,34 % 26,15 %

Firmenprofil zu ASTRAZENECA PLC Aktie

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Investierte Fonds

Folgende Fonds haben in investiert: ASTRAZENECA PLC investiert:

Fonds
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. in Mio
4.801,23
Anteil (%)
11,00 %
Fonds
iShares MSCI UK UCITS ETF GBP (Acc)
Vol. in Mio
8.928,03
Anteil (%)
7,25 %
Fonds
iShares Core FTSE 100 UCITS ETF USD Hedged (Acc)
Vol. in Mio
8.456,99
Anteil (%)
6,75 %
Fonds
iShares Core FTSE 100 UCITS ETF GBP (Acc)
Vol. in Mio
116.248,56
Anteil (%)
6,75 %
Fonds
iShares MSCI UK IMI ESG Leaders UCITS ETF GBP (Dist)
Vol. in Mio
235,17
Anteil (%)
4,34 %

Unternehmensdaten

Name ASTRAZENECA PLC
Firma AstraZeneca PLC
Website https://www.astrazeneca.com
Heimatbörse XLON London
WKN 886455
ISIN GB0009895292
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.
Marktkapitalisierung 184 Mrd.
Land Großbritannien und Nordirland
Währung GBP
Mitarbeiter 94,3 T
Adresse 1 Francis Crick Avenue, CB2 0AA Cambridge
IPO Datum 2003-12-02
Dividenden von 'ASTRAZENECA PLC'
Ex-Datum Dividende pro Aktie
20.02.2025 133,07 GBX
08.08.2024 60,92 GBX
22.02.2024 123,25 GBX
10.08.2023 56,54 GBX
23.02.2023 135,30 GBX
11.08.2022 76,40 GBX
24.02.2022 108,01 GBX
12.08.2021 46,82 GBX
25.02.2021 98,00 GBX
13.08.2020 53,26 GBX

Ticker Symbole

Name Symbol
Frankfurt ZEG.F
London AZN.L
XETRA ZEG.DE

Weitere Aktien

Investoren die ASTRAZENECA PLC die halten, haben auch folgende Aktien im Depot:
AGNC INVESTMENT CORP
AGNC INVESTMENT CORP Aktie
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Aktie
AMAZON.CO INC
AMAZON.CO INC Aktie
AMGEN INC
AMGEN INC Aktie
AMUNDI INTERNETAKTIEN
AMUNDI INTERNETAKTIEN Fonds
AMUNDI RESPONSIBLE INVESTING - IMPACT GREEN BONDS - I2 (C)
AMUNDI RESPONSIBLE INVESTING - IMPACT GREEN BONDS - I2 (C) ETF
APPLE INC
APPLE INC Aktie
BERKSHIRE HATHAWAY INC - CLASS B
BERKSHIRE HATHAWAY INC - CLASS B Aktie
META PLATFORMS INC
META PLATFORMS INC Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NVIDIA CORP
NVIDIA CORP Aktie
TESLA INC
TESLA INC Aktie
VERI ETF-ALL.DEFENSIVE R
VERI ETF-ALL.DEFENSIVE R Fonds
VISA INC - CLASS A
VISA INC - CLASS A Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025